255 related articles for article (PubMed ID: 25637475)
1. Insulin resistance and hyperandrogenism have no substantive association with birth weight in adolescents with polycystic ovary syndrome.
Fulghesu AM; Manca R; Loi S; Fruzzetti F
Fertil Steril; 2015 Mar; 103(3):808-14. PubMed ID: 25637475
[TBL] [Abstract][Full Text] [Related]
2. Ovarian hyperandrogenism in adolescents and young women with type I diabetes is primarily related to birth weight and body mass index.
Bizzarri C; Benevento D; Ravà L; Patera IP; Schiaffini R; Ciampalini P; Giannone G; Cappa M
Fertil Steril; 2011 Dec; 96(6):1497-1502.e1. PubMed ID: 21982726
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
[TBL] [Abstract][Full Text] [Related]
4. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
[TBL] [Abstract][Full Text] [Related]
5. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
6. Smoking is associated with increased free testosterone and fasting insulin levels in women with polycystic ovary syndrome, resulting in aggravated insulin resistance.
Cupisti S; Häberle L; Dittrich R; Oppelt PG; Reissmann C; Kronawitter D; Beckmann MW; Mueller A
Fertil Steril; 2010 Jul; 94(2):673-7. PubMed ID: 19394003
[TBL] [Abstract][Full Text] [Related]
7. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
[TBL] [Abstract][Full Text] [Related]
9. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
[TBL] [Abstract][Full Text] [Related]
10. Opposing effects of dehydroepiandrosterone sulfate and free testosterone on metabolic phenotype in women with polycystic ovary syndrome.
Lerchbaum E; Schwetz V; Giuliani A; Pieber TR; Obermayer-Pietsch B
Fertil Steril; 2012 Nov; 98(5):1318-25.e1. PubMed ID: 22835450
[TBL] [Abstract][Full Text] [Related]
11. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
[TBL] [Abstract][Full Text] [Related]
12. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
Barber TM; Wass JA; McCarthy MI; Franks S
Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
14. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome.
Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB
Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061
[TBL] [Abstract][Full Text] [Related]
15. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
[TBL] [Abstract][Full Text] [Related]
16. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
Paradisi G; Steinberg HO; Shepard MK; Hook G; Baron AD
J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
[TBL] [Abstract][Full Text] [Related]
17. Improvement of hyperandrogenism and hyperinsulinemia during pregnancy in women with polycystic ovary syndrome: possible effect in the ovarian follicular mass of their daughters.
Crisosto N; Echiburú B; Maliqueo M; Pérez V; Ladrón de Guevara A; Preisler J; Sánchez F; Sir-Petermann T
Fertil Steril; 2012 Jan; 97(1):218-24. PubMed ID: 22088206
[TBL] [Abstract][Full Text] [Related]
18. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
19. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
Legro RS; Castracane VD; Kauffman RP
Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
[TBL] [Abstract][Full Text] [Related]
20. Basal metabolic rate is decreased in women with polycystic ovary syndrome and biochemical hyperandrogenemia and is associated with insulin resistance.
Georgopoulos NA; Saltamavros AD; Vervita V; Karkoulias K; Adonakis G; Decavalas G; Kourounis G; Markou KB; Kyriazopoulou V
Fertil Steril; 2009 Jul; 92(1):250-5. PubMed ID: 18678372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]